-
6
-
-
33646932157
-
-
Y. Liu, R.D. Goff, D. Zhou, J. Mattner, B.A. Sullivan, A. Khurana, C. Cantu III, E.V. Ravkov, C.C. Ibegbu, J.D. Altman, L. Teyton, A. Bendelac, and P.B. Savage J. Immunol. Methods 312 2006 34
-
(2006)
J. Immunol. Methods
, vol.312
, pp. 34
-
-
Liu, Y.1
Goff, R.D.2
Zhou, D.3
Mattner, J.4
Sullivan, B.A.5
Khurana, A.6
Cantu III, C.7
Ravkov, E.V.8
Ibegbu, C.C.9
Altman, J.D.10
Teyton, L.11
Bendelac, A.12
Savage, P.B.13
-
7
-
-
61849162798
-
-
K. Kadoshima-Yamaoka, M. Murakawa, M. Goto, Y. Tanaka, H. Inoue, H. Murafuji, A. Nagahira, J. Hayashi, K. Nagahira, K. Miura, T. Nakatsuka, K. Chamoto, Y. Fukuda, and T. Nishimura Immunol. Lett. 122 2009 193
-
(2009)
Immunol. Lett.
, vol.122
, pp. 193
-
-
Kadoshima-Yamaoka, K.1
Murakawa, M.2
Goto, M.3
Tanaka, Y.4
Inoue, H.5
Murafuji, H.6
Nagahira, A.7
Hayashi, J.8
Nagahira, K.9
Miura, K.10
Nakatsuka, T.11
Chamoto, K.12
Fukuda, Y.13
Nishimura, T.14
-
8
-
-
58149474535
-
-
K. Kadoshima-Yamaoka, M. Murakawa, M. Goto, Y. Tanaka, H. Inoue, H. Murafuji, A. Nagahira, J. Hayashi, K. Nagahira, K. Miura, T. Nakatsuka, K. Chamoto, Y. Fukuda, and T. Nishimura Int. Immunopharmacol. 9 2009 97
-
(2009)
Int. Immunopharmacol.
, vol.9
, pp. 97
-
-
Kadoshima-Yamaoka, K.1
Murakawa, M.2
Goto, M.3
Tanaka, Y.4
Inoue, H.5
Murafuji, H.6
Nagahira, A.7
Hayashi, J.8
Nagahira, K.9
Miura, K.10
Nakatsuka, T.11
Chamoto, K.12
Fukuda, Y.13
Nishimura, T.14
-
9
-
-
77949914789
-
-
M. Goto, K. Kadoshima-Yamaoka, M. Murakawa, R. Yoshioka, Y. Tanaka, H. Inoue, H. Murafuji, S. Kanki, J. Hayashi, K. Nagahira, A. Ogata, T. Nakatsuka, and Y. Fukuda Eur. J. Pharmacol. 633 2010 93
-
(2010)
Eur. J. Pharmacol.
, vol.633
, pp. 93
-
-
Goto, M.1
Kadoshima-Yamaoka, K.2
Murakawa, M.3
Yoshioka, R.4
Tanaka, Y.5
Inoue, H.6
Murafuji, H.7
Kanki, S.8
Hayashi, J.9
Nagahira, K.10
Ogata, A.11
Nakatsuka, T.12
Fukuda, Y.13
-
10
-
-
0041695221
-
-
S. Perez-Torres, R. Cortes, M. Tolnay, A. Probst, J.M. Palacios, and G. Mengod Exp. Neurol. 182 2003 322
-
(2003)
Exp. Neurol.
, vol.182
, pp. 322
-
-
Perez-Torres, S.1
Cortes, R.2
Tolnay, M.3
Probst, A.4
Palacios, J.M.5
Mengod, G.6
-
12
-
-
80054760206
-
-
PCT Int. Appl. WO 129036 A1
-
Bergmann, J. E.; Cutshall, N. S.; Demopulos, G. A.; Florio, V. A.; Gaitanaris, G.; Gray, P.; Hohmann, J.; Onrust, R.; Zeng, H. PCT Int. Appl. WO 129036 A1, 2010.
-
(2010)
-
-
Bergmann, J.E.1
Cutshall, N.S.2
Demopulos, G.A.3
Florio, V.A.4
Gaitanaris, G.5
Gray, P.6
Hohmann, J.7
Onrust, R.8
Zeng, H.9
-
15
-
-
24744456706
-
-
H. Wang, Y. Liu, Y. Chen, H. Robinson, and H.J. Ke Biol. Chem. 280 2005 30949
-
(2005)
Biol. Chem.
, vol.280
, pp. 30949
-
-
Wang, H.1
Liu, Y.2
Chen, Y.3
Robinson, H.4
Ke, H.J.5
-
16
-
-
33645896811
-
-
The Oxford Molecular Group, The Medawar Centre, Oxford Science Park, Oxford OX4 4GA, UK
-
Clark, T., Alex, A., Beck, B., Chandrasekhar, J., Gedeck, P., Horn, A., Hutter, M., Martin, B., Rauhut, G., Sauer, W., Schindler, T., and Steinke, T. vamp (version 7.5a). 1999, The Oxford Molecular Group, The Medawar Centre, Oxford Science Park, Oxford OX4 4GA, UK.
-
(1999)
Vamp (Version 7.5a)
-
-
Clark, T.1
Alex, A.2
Beck, B.3
Chandrasekhar, J.4
Gedeck, P.5
Horn, A.6
Hutter, M.7
Martin, B.8
Rauhut, G.9
Sauer, W.10
Schindler, T.11
Steinke, T.12
-
17
-
-
80054773998
-
-
CCDC Software Ltd, Cambridge
-
GOLD (version 5.0.1). 2011, CCDC Software Ltd, Cambridge.
-
(2011)
GOLD (Version 5.0.1)
-
-
-
20
-
-
4344676386
-
-
K.Y. Zhang, G.L. Card, Y. Suzuki, D.R. Artis, D. Fong, S. Gillette, D. Hsieh, J. Neiman, B.L. West, C. Zhang, M.V. Milburn, S.H. Kim, J. Schlessinger, and G. Bollag Mol. Cell 15 2004 279
-
(2004)
Mol. Cell
, vol.15
, pp. 279
-
-
Zhang, K.Y.1
Card, G.L.2
Suzuki, Y.3
Artis, D.R.4
Fong, D.5
Gillette, S.6
Hsieh, D.7
Neiman, J.8
West, B.L.9
Zhang, C.10
Milburn, M.V.11
Kim, S.H.12
Schlessinger, J.13
Bollag, G.14
-
22
-
-
0017592139
-
-
J. Heindl, H.-W. Kelm, E. Dogs, A. Seeger, and C. Herrmann Eur. J. Med. Chem. Chim. Ther. 12 1977 549
-
(1977)
Eur. J. Med. Chem. Chim. Ther.
, vol.12
, pp. 549
-
-
Heindl, J.1
Kelm, H.-W.2
Dogs, E.3
Seeger, A.4
Herrmann, C.5
-
25
-
-
80054754535
-
-
Prepared by using 2-aminopyridine as starting material instead of A
-
Prepared by using 2-aminopyridine as starting material instead of A.
-
-
-
-
26
-
-
80054755713
-
-
Corresponds to precursor F in the preparation of 3
-
Corresponds to precursor F in the preparation of 3.
-
-
-
-
27
-
-
80054756454
-
-
Prepared from the corresponding ethyl ester intermediate F
-
Prepared from the corresponding ethyl ester intermediate F.
-
-
-
-
28
-
-
84857505635
-
-
2, reflux)
-
2, reflux).
-
-
-
-
29
-
-
84857503342
-
-
50 values are means of at least four experiments
-
50 values are means of at least four experiments.
-
-
-
|